Showdown Looms in Congress Over Drug Advertising on TV
The FDA is salivating in expectation of increased funding from the drug industry–ostensibly to speed up the reviewing process for TV ads.
-
-
-
A Disease for Every Pill – FDA Hearing Drug Advertising
A Disease for Every Pill – FDA Hearing Drug Advertising Wed, 5 Oct 2005 The FDA has called for a public hearing to address direct to consumer drug advertising. Hearing Date: November 1 and 2, 2005 Hearing Name: Direct-To-Consumer Promotion Location: National Transportation Safety Board Boardroom and Conference Center 429…
-
Daniel Troy Legacy: Public Virtually Defenseless against Unsafe Drugs
Daniel Troy Legacy: Public Virtually Defenseless against Unsafe Drugs Thu, 18 Nov 2004 The Associated Press reports that at a Congressional hearing today, Dr. David Graham a drug safety expert at the FDA told the Senate Finance Committee that the public is “virtually defenseless” if another medication such as Vioxx…
-
VIOXX WITHDRAWAL: FDA TO JOIN AUDIO CONFERENCE ON NOVEMBER 10
VIOXX WITHDRAWAL: FDA TO JOIN AUDIO CONFERENCE ON NOVEMBER 10 Mon, 8 Nov 2004 To hear from FDA Office of New Drugs Acting Director Sandra Kweder, MD, in an interactive discussion of what the withdrawal of the blockbuster drug means for the agencys drug safety programs, the COX-2 inhibitor class…
-
Sen Grassley Expands Investigation – Why did FDA approve Vioxx for Children???
Sen Grassley Expands Investigation – Why did FDA approve Vioxx for Children??? Mon, 18 Oct 2004 The Financial Times of London and The Washington Post report that the Senate Finance Committee is expanding its probe of the FDA and its cosy relationship with drug manufacturers. The Vioxx debacle is but…
-
NJ: Mandatory Mental Screening Women_Pill Pushers: NO Science, Salesmanship_FORBES
Three reports illustrate the wide and deepening disconnect between medicine under the influence of pharmaceutical industry marketing goals and scientific evidence that contradicts current practice and public health policies:
-
Disease Mongering_Conference / PLoS Special Issue
"Are we becoming patients for profit? That is the question knowledgeable observers are asking.
-
London Drug Trial Catastrophe: Collapse of Science and Ethics
The independent Institute of Science in Society (ISIS) challenges the report issued by the UK government medicines oversight agency, MHRA (equivalent to US FDA), absolving itself and those involved from any responsibility for a catastrophic human experiment that nearly killed six healthy volunteers.
-
"Lilly is Hiding Negative Information About Zyprexa" – SAPS
“Lilly is Hiding Negative Information About Zyprexa” – SAPS Wed, 2 Nov 2005 From our colleague in Sweden: A published interview with Dr. Curt Furberg, Professor of Public Health Sciences Wake Forest University Baptist Medical Center, and Chair, Steering Committee, and Principal Investigator, of one of the most important studies…
-
The Power of $4 bill Drug Ads: Doctors Respond with Diagnosis & Prescription – WashPost
The Power of $4 bill Drug Ads: Doctors Respond with Diagnosis & Prescription – WashPost Thu, 28 Apr 2005 What does $4 billion dollars in drug advertising buy? The Washington Post reports that a University of Washington study published in the Journal of the American Medical Association confirms the insidious…